<DOC>
	<DOCNO>NCT00346086</DOCNO>
	<brief_summary>Various chemical modification allergen attempt enhance efficacy , improve safety , foster compliance IT . These approach unsuccessful - allergenicity immunogenicity either decrease , increase tandem , resultant efficacy : safety benefit ratio . This study utilize adjuvant approach synthetic immunostimulatory DNA conjugate ragweed allergen attempt modulate clinical immunologic allergic response ragweed exposure ragweed-allergic patient seasonal rhinitis .</brief_summary>
	<brief_title>DNA Vaccine Ragweed Allergic Adults</brief_title>
	<detailed_description>Evaluation efficacy safety allergen-CpG oligonucleotide immunostimulatory conjugate treatment ragweed-induced seasonal allergic rhinitis . Study incorporate clinical outcome ( symptom diary , medication diary , visual analog score , quality life questionnaire ) , safety measurement , immunologic assay ( antibody measurement , T-cell assay , cytokine assay , nasal provocation ) .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Adult men woman 18 60 year age ; Who provide informed consent ; Have history fall , seasonal , allergic rhinitis consistent ragweed allergy ; Exhibit postiive skin test license , standardize , ragweed extract positive acute response ragweed nasal challenge ; Are general good health ; available duration study . Individuals medical condition take medication might interfere interpretation study result exclude . Those history severe symptom allergic rhinitis spring summer grass pollen season exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>CpG oligonucleotide vaccine</keyword>
	<keyword>ragweed immunotherapy</keyword>
</DOC>